MYGN CapEx to Revenue

Myriad Genetics Inc · CapEx to Revenue

MYGN logo

MYGN CapEx to Revenue

Current (TTM)2.02%
MYGN CapEx/Revenue (96.97% → 2.02%)
High-resolution chart · PNG

MYGN capex to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Myriad Genetics Inc CapEx to Revenue — Annual fiscal periods
Period endingCapEx to Revenue
3.3232%
3.5458%
9.7318%
6.6775%
2.6064%
2.3698%
1.5972%
1.0105%
1.1295%
0.8371%
0.6752%
3.3052%
1.8376%
1.8591%
2.048%
1.4405%
2.177%
2.3046%
6.1363%
7.2553%
6.7204%
8.1742%
6.8546%
12.4936%
12.7288%
11.6363%
13.5748%
15.8103%
13.7931%
30.9211%
96.9697%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.